Overview
Tilmanocept marketed under the name Lymphoseek is a Tc99m labeled receptor targeted agent for sentinel lymph node mapping that binds mannose receptors in lymphatic tissue.
Properties
Small molecule radiopharmaceutical that is retained in sentinel nodes and provides reliable localization for surgical planning and intraoperative guidance.
Uses
Used in breast cancer and melanoma sentinel node mapping and in other cancers where sentinel node staging is indicated.
Safety
Low radiation exposure; follow recommended injection and imaging protocols and monitor for rare allergic reactions.